Roche contends with loss of momentum for key medicines, currency fluctuations in Q3 but keeps growth on track

23rd October 2025 Uncategorised 0

Even as Roche executives on Wednesday espoused confidence in the company’s resilience and growth potential over the next several years, a mix of exchange rate fluctuations and lackluster pharmaceutical sales led to a worse-than-expected third quarter for the Swiss drug giant.

More: Roche contends with loss of momentum for key medicines, currency fluctuations in Q3 but keeps growth on track
Source: fierce